{"id":"https://openalex.org/W2408820156","doi":null,"title":"Ceftazidime in the treatment of Pseudomonas infections in intensive-care patients.","display_name":"Ceftazidime in the treatment of Pseudomonas infections in intensive-care patients.","alternate_titles":[],"publication_year":1986,"publication_date":"1986-09-01","ids":{"openalex":"https://openalex.org/W2408820156","mag":"2408820156","pmid":"https://pubmed.ncbi.nlm.nih.gov/3536763"},"language":"en","primary_location":{"id":"pmid:3536763","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3536763","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology, therapy, and toxicology","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2408820156"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009406096","display_name":"Renato Rondanelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25217355","display_name":"University of Pavia","ror":"https://ror.org/00s6t1f81","country_code":"IT","type":"education","lineage":["https://openalex.org/I25217355"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"R Rondanelli","raw_affiliation_strings":["University of Pavia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pavia","institution_ids":["https://openalex.org/I25217355"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111822789","display_name":"R Dionigi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25217355","display_name":"University of Pavia","ror":"https://ror.org/00s6t1f81","country_code":"IT","type":"education","lineage":["https://openalex.org/I25217355"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"R V Dionigi","raw_affiliation_strings":["University of Pavia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pavia","institution_ids":["https://openalex.org/I25217355"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108501150","display_name":"Mario Bonora Regazzi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151645","display_name":"Policlinico San Matteo Fondazione","ror":"https://ror.org/05w1q1c88","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210151645","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M B Regazzi","raw_affiliation_strings":["IRCCS Fondazione Policlinico San Matteo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IRCCS Fondazione Policlinico San Matteo","institution_ids":["https://openalex.org/I4210151645"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108493214","display_name":"Marco Maurelli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Maurelli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"M Calvi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151645","display_name":"Policlinico San Matteo Fondazione","ror":"https://ror.org/05w1q1c88","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210151645","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M Calvi","raw_affiliation_strings":["IRCCS Fondazione Policlinico San Matteo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IRCCS Fondazione Policlinico San Matteo","institution_ids":["https://openalex.org/I4210151645"]}]},{"author_position":"last","author":{"id":null,"display_name":"A Mapelli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Mapelli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"24","issue":"9","first_page":"457","last_page":"459"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ceftazidime","display_name":"ceftazidime","score":1.0},{"id":"https://openalex.org/keywords/pseudomonas-infection","display_name":"Pseudomonas infection","score":0.9890000224113464},{"id":"https://openalex.org/keywords/intensive-care-unit-patients","display_name":"intensive care unit patients","score":0.9079999923706055},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9909999966621399},{"id":"https://openalex.org/keywords/plasma-concentration","display_name":"plasma concentration","score":0.5630000233650208},{"id":"https://openalex.org/keywords/plasma-half-life","display_name":"plasma half-life","score":0.8309999704360962},{"id":"https://openalex.org/keywords/volume-of-distribution","display_name":"volume of distribution","score":0.9380000233650208},{"id":"https://openalex.org/keywords/continuous-infusion","display_name":"continuous infusion","score":0.4480000138282776},{"id":"https://openalex.org/keywords/antibiotic-resistance","display_name":"antibiotic resistance","score":0.42399999499320984},{"id":"https://openalex.org/keywords/pulmonary-infection","display_name":"pulmonary infection","score":0.7279999852180481},{"id":"https://openalex.org/keywords/clinical-response","display_name":"clinical response","score":0.46799999475479126},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.8479999899864197}],"concepts":[{"id":"https://openalex.org/C2776968632","wikidata":"https://www.wikidata.org/wiki/Q808845","display_name":"Ceftazidime","level":4,"score":0.9744127988815308},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7546234130859375},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6616927981376648},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.6192378997802734},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5591868162155151},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.537498950958252},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.501366376876831},{"id":"https://openalex.org/C2987404301","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care","level":2,"score":0.4193279445171356},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.411490261554718},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.317035436630249},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.2650665044784546},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.23308086395263672},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1868709921836853},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0827951431274414},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002442","descriptor_name":"Ceftazidime","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002442","descriptor_name":"Ceftazidime","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003422","descriptor_name":"Critical Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011552","descriptor_name":"Pseudomonas Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:3536763","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3536763","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology, therapy, and toxicology","raw_type":"Journal Article"},{"id":"mag:2408820156","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3536763","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1964378214","https://openalex.org/W2358380939","https://openalex.org/W2043449168","https://openalex.org/W2052589942","https://openalex.org/W2158308518","https://openalex.org/W2135669621","https://openalex.org/W2316962801","https://openalex.org/W2086864831","https://openalex.org/W1985887139"],"abstract_inverted_index":{"The":[0,18,195],"present":[1],"study":[2,25],"was":[3,68,144,163,181,200],"designed":[4],"to":[5,45,64,106],"define":[6],"the":[7,46,57,107,126,159,175,185,191,210],"clinical":[8,87,235],"activity":[9],"and":[10,33,91,96,111,154,187,224,234],"pharmacokinetics":[11],"of":[12,73,93,109,120,131,142,149,152,169,193,232],"ceftazidime":[13,132,143,153,170],"in":[14,23,70,125,221,237],"Pseudomonas":[15,51,242],"sp.":[16],"infections.":[17],"intensive":[19],"care":[20],"patients":[21,55],"included":[22],"this":[24],"were":[26,99,103,128,133,207],"hospitalized":[27],"for":[28],"at":[29,184,190],"least":[30],"2":[31,74],"weeks":[32],"have":[34],"frequently":[35],"received":[36],"antibiotic":[37],"treatment":[38,176],"which":[39],"contributed":[40],"with":[41,48,116],"poor":[42],"host":[43],"resistance":[44],"infections":[47,239],"highly":[49],"resistant":[50],"strains.":[52],"Sixteen":[53],"adult":[54],"entered":[56],"study.":[58,211],"Their":[59],"age":[60],"ranged":[61],"from":[62],"18":[63],"70":[65],"years.":[66],"Ceftazidime":[67,212],"administered":[69],"a":[71,80,117],"dose":[72],"g":[75,151],"three":[76],"times":[77],"daily":[78],"by":[79,135,241],"constant":[81],"infusion":[82],"over":[83],"20-30":[84],"min.":[85],"Frequent":[86],"assessment":[88],"multiple":[89],"cultures":[90,102],"determination":[92],"renal,":[94],"hepatic":[95],"bacteriological":[97,233],"functions":[98],"performed.":[100,129],"Bacterial":[101],"obtained":[104],"prior":[105],"beginning":[108,186],"therapy":[110],"every":[112],"2-3":[113],"days":[114],"thereafter":[115],"follow-up":[118],"period":[119],"about":[121,164],"1-2":[122],"weeks.":[123],"Pharmacokinetics":[124],"blood":[127],"Measurements":[130],"made":[134],"using":[136],"HPLC.":[137],"Mean":[138,178],"peak":[139],"serum":[140],"concentration":[141,162],"58.5":[145],"micrograms/ml":[146],"after":[147,157],"administration":[148],"2.0":[150],"eight":[155],"hours":[156,183,189],"dosing":[158],"mean":[160,196],"plasma":[161,179,226],"5":[165],"micrograms/ml.":[166],"No":[167,203],"accumulation":[168],"could":[171],"be":[172,214],"observed":[173],"during":[174],"period.":[177],"half-life":[180],"2.1":[182],"2.2":[188],"end":[192],"therapy.":[194],"apparent":[197],"volume":[198],"distribution":[199],"0.35":[201],"l/kg.":[202],"severe":[204],"adverse":[205],"effects":[206],"reported":[208],"throughout":[209],"may":[213],"effectively":[215],"used":[216],"as":[217],"single":[218],"antiinfective":[219],"agent":[220],"various":[222],"conditions":[223],"higher":[225],"concentrations":[227],"are":[228],"an":[229],"important":[230],"predictor":[231],"response":[236],"pulmonary":[238],"caused":[240],"species.":[243]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2408820156","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
